Seven Eight Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,275
Closed -$1.42M 860
2024
Q1
$1.42M Buy
+8,275
New +$1.54M 0.15% 220
2023
Q4
Sell
-49,267
Closed -$7.86M 792
2023
Q3
$7.86M Buy
49,267
+48,408
+5,635% +$10.8M 0.92% 19
2023
Q2
$248K Sell
859
-1,830
-68% -$556K 0.04% 428
2023
Q1
$858K Buy
+2,689
New +$797K 0.18% 157
2022
Q4
Sell
-1,315
Closed -$302K 582
2022
Q3
$302K Buy
+1,315
New +$329K 0.06% 375
2021
Q2
Sell
-9,900
Closed -$2.53M 677
2021
Q1
$2.53M Hold
9,900
0.58% 37
2020
Q4
$2.53M Buy
+9,900
New +$2.46M 0.58% 37
2020
Q3
Sell
-1,700
Closed -$330K 623
2020
Q2
$330K Buy
+1,700
New +$325K 0.24% 167
2020
Q1
Sell
-28,299
Closed -$4.84M 647
2019
Q4
$4.84M Buy
+28,299
New +$4.72M 0.26% 115
2018
Q1
Sell
-18,500
Closed -$1.28M 502
2017
Q4
$1.28M Buy
+18,500
New +$1.21M 0.13% 233

Other funds holding PODD

Seven Eight Capital's PODD Position: Q2 2024 in Review

Seven Eight Capital sold out of Insulet (PODD) in Q2 2024, closing a stake of 8,275 shares — an estimated $1.42M sold.

Seven Eight Capital first reported a position in PODD in Q4 2017 and held it in 10 quarters. The position peaked at $7.86M in Q3 2023. 599 funds tracked by Wall St. Rank hold PODD as of Q2 2024.

  • Seven Eight Capital reported no remaining Insulet position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 8,275 Insulet shares in Q2 2024, an estimated $1.42M.
  • Seven Eight Capital first reported a position in Insulet in Q4 2017 and held it in 10 quarters.
  • Seven Eight Capital's Insulet position peaked at $7.86M in Q3 2023.
  • 599 funds tracked by Wall St. Rank held Insulet as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.